The government’s race to secure vaccine deals makes a mockery of its own rhetoric on equitable global access, say public health and social justice organisations.
Campaigners are particularly concerned that the TPP would allow corporations from many countries to sue British governments for regulations and laws they dislike.
Patient groups and campaigners are asking AstraZeneca for full disclosure of their plans to develop a coronavirus vaccine with Oxford University, outlining the need for vaccines to be patent-free.
Successive International Development Secretaries, including current Home Secretary Priti Patel, failed to intervene to address the alleged mismanagement.
Campaigners say new trade deals must receive full parliamentary and public scrutiny, and it is difficult to see how that can be achieved when parliament has risen and the country is on lockdown.